Food, Health & Wellness News
-
Scythian Biosciences Announces Extension of Letter of Intent
March 29, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF)…
-
NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform
March 27, 2018 (Source) — Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery systems…
-
BlueOcean NutraSciences Inc./CO2GRO Inc. Corporate Update and Name Change
March 26, 2018 (Source) — BlueOcean NutraSciences Inc. (“BlueOcean” or the “Company”) (TSX-V: BOC) is pleased to provide a…
-
Global Cannabis Closes First Tranche of Private Placement
March 22, 2018 (Source) — Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE:2FA, OTCQB: FUAPF), a leading…
-
Global Cannabis To Launch Artificial Intelligence Chatbot For The Medical Cannabis Industry
March 15, 2018 (Source) — Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a…
-
Scythian Biosciences Corp. Announces Letter of Intent to Acquire Argentina-Based ABP S.A.
March 12, 2018 (Source) — Scythian takes first step into the global cannabis markets, expanding its business model and…
-
NanoSphere Health Sciences’ Cannabis Brand Now Available in Over 100 Dispensaries
March 7, 2018 (Source) — Evolve Formulas’ Transdermal NanoSerum(TM) Continues to Expand NanoSphere Health Sciences Inc. (CSE: NSHS/ OTC:…
-
BlueOcean NutraSciences Inc. Announces the Issuance of Shares for Debt
March 2, 2018 (Source) — BlueOcean NutraSciences Inc. (“BlueOcean” or the “Company”) (TSX-V: BOC) announces that in accordance with the…
-
BlueOcean NutraSciences Inc. Announces Selection to TSXV Top 50 for 2017
February 22, 2018 (Source) — BlueOcean NutraSciences Inc. (“BlueOcean” or the “Company”) (TSX VENTURE:BOC) is pleased to announce it…
-
Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell
February 22, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce…
